Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Oslo Bors
05/19/2017 05/22/2017 05/23/2017 05/24/2017 05/26/2017 Date
32.7(c) 33.7(c) 32.6(c) 32.5(c) 31.6 Last
50 403 55 767 29 566 5 655 35 068 Volume
+7.21% +3.06% -3.26% -0.31% -2.77% Change
More quotes
Financials ( NOK)
Sales 2017 150 M
EBIT 2017 -37,1 M
Net income 2017 -29,6 M
Finance 2017 111 M
Yield 2017 -
Sales 2018 222 M
EBIT 2018 0,81 M
Net income 2018 1,95 M
Finance 2018 104 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 138,30
EV / Sales2017 3,92x
EV / Sales2018 2,69x
Capitalization 701 M
More Financials
Company
Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.It operates through Commercial Franchise and Development Portfolio segments.The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and... 
Sector
Pharmaceuticals
Calendar
08/23Earnings Release
More about the company
Surperformance© ratings of Photocure ASA
Trading Rating : Investor Rating :
More Ratings
Latest news on PHOTOCURE ASA
01:07p PHOTOCURE : Jeremy Bahr appointed Chief Business Officer
01:07p PHOTOCURE : Appoints Three New Members to its Board of Directors
05/23 PHOTOCURE ASA : Results for the first quarter of 2017
05/18PHOTOCURE ASA : quaterly earnings release
05/16 PHOTOCURE ASA : Presentation of the first quarter 2017 results and the results f..
05/15 PHOTOCURE : Positive data from Phase 3 US Blue Light Cystoscopy with Cysview® st..
05/12 PHOTOCURE ASA : Phase 3 study investigating Blue Light Flexible Cystoscopy with ..
05/08PHOTOCURE ASA : quaterly earnings release
05/05 PHOTOCURE : Jeremy Bahr appointed Chief Business Officer
04/28 PHOTOCURE : Appoints Three New Members to its Board of Directors
More news
Sector news : Pharmaceuticals - NEC
02:43pDJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Pharmaceuticals - NEC
Latest Tweets
01:07pPhotocure : Jeremy Bahr appointed Chief Business Officer  
05/24PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow  
05/24PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow  
05/23PhotoCure: Results For The First Quarter Of 2017  
More tweets
Qtime:2
News from SeekingAlpha
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
05/24 PhotoCure ASA (PHCUF) Updates on Bladder Cancer - Slideshow
Advertisement
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 36,0  NOK
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Jan Hendrik Egberts Chairman
Erik Dahl Chief Financial Officer & IR Contact
Inger Ferner Heglund Vice President-Research & Development
Xavier Denis Yon Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA-22.62%83
JOHNSON & JOHNSON10.68%343 545
ROCHE HOLDING LTD.14.88%236 038
NOVARTIS AG6.68%212 104
PFIZER INC.-1.32%191 517
MERCK & CO., INC.10.48%177 895
More Results